Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2015, Article ID 241738, 9 pages
http://dx.doi.org/10.1155/2015/241738
Clinical Study

Cytokines Modulate the “Immune-Metabolism” Interactions during Behçet Disease: Effect on Arginine Metabolism

1USTHB, “Cytokines and NO Synthases” Team, LBCM, FSB, BP 32 El Alia, Bab Ezzouar, 16111 Algiers, Algeria
2Internal Medicine Department, CHU Mustapha Bacha, Algiers, Algeria
3Internal Medicine Department, CHU Bab El Oued, Algiers, Algeria
4Ophthalmology Department, CHU Ibn Rochd, Annaba, Algeria
5EA 2216, UBO, Brest, France

Received 13 June 2014; Revised 15 September 2014; Accepted 4 November 2014

Academic Editor: John Ryan

Copyright © 2015 Houda Belguendouz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Hirohata and H. Kikuchi, “Behçet's disease,” Arthritis Research and Therapy, vol. 5, no. 3, pp. 139–146, 2003. View at Google Scholar · View at Scopus
  2. A. A. Okada, “Behçet’s disease: general concepts and recent advances,” Current Opinion in Ophthalmology, vol. 17, pp. 551–556, 2006. View at Google Scholar
  3. F. Davatchi, S. Assaad-Khalil, K. T. Calamia et al., “The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria,” Journal of the European Academy of Dermatology and Venereology, vol. 28, no. 3, pp. 338–347, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. E. Deuter, I. Kötter, G. R. Wallace, P. I. Murray, N. Stübiger, and M. Zierhut, “Behçet's disease: ocular effects and treatment,” Progress in Retinal and Eye Research, vol. 27, no. 1, pp. 111–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. P. de Chambrun, B. Wechsler, G. Geri, P. Cacoub, and D. Saadoun, “New insights into the pathogenesis of Behçet's disease,” Autoimmunity Reviews, vol. 11, no. 10, pp. 687–698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kurhan-Yavuz, H. Direskeneli, N. Bozkurt et al., “Anti-MHC autoimmunity in Behçet’s disease: T cell responses to an HLA-B derived peptide cross-reactive with retinal-S antigen in patients with uveitis,” Clinical and Experimental Immunology, vol. 120, no. 1, pp. 162–166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Takeuchi, Y. Usui, Y. Okunuki et al., “Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behçet's patients with uveitis,” Investigative Ophthalmology & Visual Science, vol. 51, no. 6, pp. 3067–3075, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Direskeneli, “Autoimmunity vs autoinflammation in Behçet's disease: do we oversimplify a complex disorder?” Rheumatology, vol. 45, no. 12, pp. 1461–1465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. F. S. Neves and F. Spiller, “Possible mechanisms of neutrophil activation in Behçet's disease,” International Immunopharmacology, vol. 17, no. 4, pp. 1206–1210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Yavuz, Y. Elbir, A. Tulunay, E. Eksioglu-Demiralp, and H. Direskeneli, “Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behçet's disease etiopathogenesis,” Rheumatology International, vol. 28, no. 5, pp. 401–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Liu, C. Wang, Z. Ye, A. Kijlstra, and P. Yang, “Higher expression of toll-like receptors 2, 3, 4, and 8 in ocular Behçet's disease,” Investigative Ophthalmology & Visual Science, vol. 54, no. 9, pp. 6012–6017, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Y. Zhou, S. L. Chen, N. Shen, and Y. Lu, “Cytokines and Behçet's Disease,” Autoimmunity Reviews, vol. 11, no. 10, pp. 699–704, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-L. Mege, N. Dilsen, and V. Sanguedolce, “Overproduction of monocyte derived TNF, Interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects,” The Journal of Rheumatology, vol. 20, no. 9, pp. 1544–1549, 1993. View at Google Scholar
  14. A. M. Dalghous, J. Freysdottir, and F. Fortune, “Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behçet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD,” Scandinavian Journal of Rheumatology, vol. 35, no. 6, pp. 472–475, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Suzuki, K. Nara, and T. Suzuki, “Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behçet's disease,” Clinical Medicine and Research, vol. 4, no. 2, pp. 147–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Guenane, D. Hartani, L. Chachoua, O. S. Lahlou-Boukoffa, F. Mazari, and C. Touil-Boukoffa, “Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis,” Journal Français d'Ophtalmologie, vol. 29, no. 2, pp. 146–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Belguendouz, D. Messaoudène, K. Lahmar et al., “Interferon-γ and nitric oxide production during Behçet uveitis: immunomodulatory effect of interleukin-10,” Journal of Interferon & Cytokine Research, vol. 31, no. 9, pp. 643–651, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Messaoudene, H. Belguendouz, M. Ahmedi et al., “Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease,” Journal of Inflammation, vol. 8, article 35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Djaballah-Ider, S. Chaib, H. Belguendouz, D. Talbi, and C. Touil-Boukoffa, “T cells activation and interferon-γ/nitric oxide production during behçet disease: a study in Algerian patients,” Ocular Immunology and Inflammation, vol. 20, no. 3, pp. 215–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Belguendouz, D. Messaoudene, D. Hartani et al., “Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Behçet and idiopathic uveitis,” Journal Français d'Ophtalmologie, vol. 31, no. 4, pp. 387–395, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bogdan, “The multiplex function of nitric oxide in (auto)immunity,” Journal of Experimental Medicine, vol. 187, no. 9, pp. 1361–1365, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. B. R. Flam, D. C. Eichler, and L. P. Solomonson, “Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle,” Nitric Oxide, vol. 17, no. 3-4, pp. 115–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Morris Jr., “Recent advances in arginine metabolism: roles and regulation of the arginases,” British Journal of Pharmacology, vol. 157, no. 6, pp. 922–930, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Husson, C. Brasse-Lagnel, A. Fairand, S. Renouf, and A. Lavoinne, “Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle,” European Journal of Biochemistry, vol. 270, no. 9, pp. 1887–1899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Tabacco, F. Meiattini, E. Moda, and P. Tarli, “Simplified enzymic/colorimetric serum urea nitrogen determination,” Clinical Chemistry, vol. 25, no. 2, pp. 336–337, 1979. View at Google Scholar · View at Scopus
  26. C. Touil-Boukoffa, B. Bauvois, J. Sancéau, B. Hamrioui, and J. Wietzerbin, “Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-γ levels,” Biochimie, vol. 80, no. 8-9, pp. 739–744, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Bansal and J. B. Ochoa, “Arginine availability, arginase, and the immune response,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 6, no. 2, pp. 223–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Barksdale, A. C. Bernard, M. E. Maley et al., “Regulation of arginase expression by T-helper II cytokines and isoproterenol,” Surgery, vol. 135, no. 5, pp. 527–535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Hamzaoui, E. Bouali, I. Ghorbel, M. Khanfir, H. Houman, and A. Hamzaoui, “Expression of Th-17 and RORγt mRNA in Behçet's disease,” Medical Science Monitor, vol. 17, no. 4, pp. CR227–CR234, 2011. View at Google Scholar · View at Scopus
  30. W. Chi, X. Zhu, P. Yang et al., “Upregulated IL-23 and IL-17 in Behçet patients with active uveitis,” Investigative Ophthalmology and Visual Science, vol. 49, no. 7, pp. 3058–3064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. F. Remmers, F. Cosan, Y. Kirino et al., “Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease,” Nature Genetics, vol. 42, no. 8, pp. 698–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Montes-Cano, M. Conde-Jaldón, J. R. García-Lozano et al., “HLA and non-HLA genes in Behçet's disease: a multicentric study in the Spanish population,” Arthritis Research & Therapy, vol. 15, no. 5, article R145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Çavuş, C. Ulusoy, A. Örçen, A. Gül, E. Tüzün, and B. Vural, “Increased IL-23 receptor, TNF-α and IL-6 expression in individuals with the IL23R-IL12RB2 locus polymorphism,” Immunology Letters, vol. 160, no. 1, pp. 96–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. O. K. D. Naib, M. Aribi, A. Idder et al., “Association analysis of IL10, TNF-α, and IL23R-IL12RB2 SNPs with Behçet’s disease risk in Western Algeria,” Frontiers in Immunology, vol. 4, article 342, 2013. View at Publisher · View at Google Scholar
  35. V. G. Kaklamani, M. Sadim, Y. Koumantaki, P. Kaklamanis, and B. Pasche, “Role of polymorphisms in Adamantiades-Behçet's disease,” The Journal of Rheumatology, vol. 35, no. 12, pp. 2376–2378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Dilek, A. A. Özçimen, H. Sancaoğlu et al., “Cytokine gene polymorphisms in Behçet's disease and their association with clinical and laboratory findings,” Clinical and Experimental Rheumatology, vol. 27, supplement 53, no. 2, pp. S73–S78, 2009. View at Google Scholar · View at Scopus
  37. F. Shahram, E. Nikoopour, N. Rezaei et al., “Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behçet's disease,” Clinical & Experimental Rheumatology, vol. 29, no. 4, supplement 67, pp. S28–S31, 2011. View at Google Scholar · View at Scopus
  38. H. K. Chang, W. C. Jang, S. B. Park et al., “Association between interleukin 6 gene polymorphisms and Behçet's disease in Korean people,” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 339–340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. R. M. Talaat, M. E. Ashour, I. H. Bassyouni, and A. A. Raouf, “Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behçet's disease,” Immunobiology, vol. 219, no. 8, pp. 573–582, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Evereklioglu, Y. Turkoz, H. Er, H. S. Inaloz, E. Ozbek, and M. Cekmen, “Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?” Journal of the American Academy of Dermatology, vol. 46, no. 1, pp. 50–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. İşcan, U. Yiğit, B. Ç. Tuğcu et al., “Tear nitric oxide levels in Behçet's disease,” Medicina (Kaunas), vol. 48, no. 11, pp. 559–562, 2012. View at Google Scholar
  42. R. Radi, “Peroxynitrite, a stealthy biological oxidant,” The Journal of Biological Chemistry, vol. 288, no. 37, pp. 26464–26472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Mori, “Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling,” The Journal of Nutrition, vol. 137, supplement 2, no. 6, pp. 1616S–1620S, 2007. View at Google Scholar · View at Scopus
  44. Y. Xia, V. L. Dawson, T. M. Dawson, S. H. Snyder, and J. L. Zweier, “Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 13, pp. 6770–6774, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Xia and J. L. Zweier, “Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 13, pp. 6954–6958, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Durante, F. K. Johnson, and R. A. Johnson, “Arginase: a critical regulator of nitric oxide synthesis and vascular function,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 9, pp. 906–911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. Cui, R. Tuladhar, S. L. Hart, M. S. Marber, J. D. Pearson, and A. R. Baydoun, “Rate of transport of L-arginine is independent of the expression of inducible nitric oxide synthase in HEK 293 cells,” Nitric Oxide, vol. 12, no. 1, pp. 21–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. C. J. Meininger and W. U. Guoyao, “L-glutamine inhibits nitric oxide synthesis in bovine venular endothelial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 281, no. 1, pp. 448–453, 1997. View at Google Scholar · View at Scopus
  49. T. A. Gheita, H. Raafat, H. Khalil, and H. Hussein, “Serum level of APRIL/BLyS in Behçet's disease patients: clinical significance in uveitis and disease activity,” Modern Rheumatology, vol. 23, no. 3, pp. 542–546, 2013. View at Publisher · View at Google Scholar · View at Scopus